Financhill
Back

CureVac NV Quote, Financials, Valuation and Earnings

CureVac NV Price Quote

$2.89
+0.01 (+-3.34%)
(Updated: December 21, 2024 at 5:22 AM ET)

CureVac NV Key Stats

Sell
30
CureVac NV (CVAC) is a Sell

Day range:
$2.83 - $3.02
52-week range:
$2.22 - $5.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.09
P/B ratio:
0.8%

Volume:
817.8K
Avg. volume:
615.4K
1-year change:
-27.15%
Market cap:
$647.2M
Revenue:
$58.2M
EPS:
$0.55

How Much Does CureVac NV Make?

Data Unavailable

Is CureVac NV Growing As A Company?

Data Unavailable

CureVac NV Stock Price Performance

  • Did CureVac NV Stock Go Up Last Month?
    CureVac NV share price went up by 15.86% last month
  • Did CVAC's Share Price Rise Over The Last Year?
    CVAC share price fell by -27.15% over the past 1 year

What Is CureVac NV 52-Week High & Low?

  • What Is CureVac NV’s 52-Week High Share Price?
    CureVac NV has traded as high as $5.28 over the past 52 weeks
  • What Is CureVac NV’s 52-Week Low Share Price?
    CureVac NV has traded as low as $2.22 over the past 52 weeks

CureVac NV Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CureVac NV?

Data Unavailable

Is CureVac NV Cash Flow Positive?

Data Unavailable

CureVac NV Return On Invested Capital

Data Unavailable

CureVac NV Earnings Date & Stock Price

  • What Is CureVac NV's Stock Price Today?
    A single share of CVAC can be purchased today for 2.89
  • What Is CureVac NV’s Stock Symbol?
    CureVac NV trades on the nasdaq under the ticker symbol: CVAC
  • When Is CureVac NV’s Next Earnings Date?
    The next quarterly earnings date for CureVac NV is scheduled on April 24, 2025
  • When Is CVAC's next ex-dividend date?
    CureVac NV's next ex-dividend date is December 22, 2024
  • How To Buy CureVac NV Stock?
    You can buy CureVac NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

CureVac NV Competitors

  • Who Are CureVac NV's Competitors?
    Below is a list of companies who compete with CureVac NV or are related in some way:

CureVac NV Dividend Yield

Data Unavailable

CureVac NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.84%
Revenue: 2926.77% 249.7%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 7.38
Upside from Last Price: 155.64%

Major Shareholders

Data Unavailable